Page last updated: 2024-11-13

mephedrone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

mephedrone: a beta-keto (bk) designer drug; Central Nervous System Stimulants [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

mephedrone : An aromatic ketone that is propiophenone substituted at C-4 and at C-beta with methyl and methylamino groups respectively. It is a synthetic stimulant and entactogen drug of the amphetamine and cathinone classes. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID45266826
CHEMBL ID4094396
CHEBI ID59331
SCHEMBL ID727913
MeSH IDM0544970

Synonyms (36)

Synonym
2-(methylamino)-1-(4-methylphenyl)propan-1-one
4-methylephedrone
4-mmc
CHEBI:59331 ,
1189805-46-6
4-mmc compound
mephedrone
mmcat compound
bk-4-methylmethamphetamine
4-methylmethcathinone
beta-keto-4-methylmethamphetamine
hsdb 7979
dea no. 1248
bounce
meow meow
m-cat
8ba8t27317 ,
1-propanone, 2-(methylamino)-1-(4-methylphenyl)-
mad cow
unii-8ba8t27317
bubbles
j2.756.280i ,
2-methylamino-1-p-tolylpropane-1-one
SCHEMBL727913
YELGFTGWJGBAQU-UHFFFAOYSA-N
1-(4-methylphenyl)-2-methylaminopropan-1-one
2-(methylamino)-1-(4-methylphenyl)-1-propanone
88783-39-5
DB13108
DTXSID20891437 ,
FT-0701141
Q262613
bdbm50236718
CHEMBL4094396 ,
(rs)-2-methylamino-1-(4-methylphenyl)propan-1-one
dtxcid30888999

Research Excerpts

Overview

Mephedrone (MEP) is an illicit stimulant drug that belongs to the synthetic cathinone (SC) class. It has been widely used for recreational purposes and reported in forensic analysis. It exerts its effects by interacting with monoamine transporters.

ExcerptReferenceRelevance
"Mephedrone (MEP) is an illicit stimulant drug that belongs to the synthetic cathinone (SC) class, which has been widely used for recreational purposes and reported in forensic analysis. "( Electrochemical detection of mephedrone using a graphene screen-printed electrode: a new sensitive and selective approach to identify synthetic cathinones in forensic analysis.
Aranha, LMS; Arantes, LC; Conceição, NS; Dos Santos, WTP; Ferreira, RQ; Lima, CD; Marinho, PA; Melo, LMA; Schaffel, IF, 2023
)
2.64
"Mephedrone is a representative of synthetic cathinones that is known from its rewarding and psychostimulant effects. "( The L-arginine-NO-cGMP pathway mediates the locomotor activity alterations during the expression of sensitization to mephedrone in mice.
Bederska-Łojewska, D; Bielecka-Papierz, G; Jakóbczuk, M; Listos, J; Orzelska-Górka, J; Poleszak, E; Serefko, A; Szewczyk, B; Szopa, A; Szponar, J; Talarek, S; Turek, J, 2023
)
2.56
"Mephedrone is a popular synthetic cathinone, known for its psychostimulant effects. "( Pharmacokinetics of Mephedrone and Its Metabolites in Whole Blood and Plasma after Controlled Intranasal Administration to Healthy Human Volunteers.
Abbate, V; Czerwinska, J; Dargan, PI; George, C; Kicman, AT; Parkin, MC, 2021
)
2.39
"Mephedrone is a widely used drug of abuse, exerting its effects by interacting with monoamine transporters. "( Insight into Glutamatergic Involvement in Rewarding Effects of Mephedrone in Rats: In Vivo and Ex Vivo Study.
Boguszewska-Czubara, A; Budzyńska, B; Kochalska, K; Kozioł, P; Kurach, Ł; Kurzepa, J; Michalak, A; Pankowska, A; Pietura, R; Słowik, T; Talarek, S; Wronikowska, O; Zykubek, M; Łazorczyk, A, 2021
)
2.3
"Mephedrone is a frequently overused drug of abuse that belongs to the group of novel psychoactive substances. "( Vulnerability factors for mephedrone-induced conditioned place preference in rats-the impact of sex differences, social-conditioning and stress.
Boguszewska-Czubara, A; Budzyńska, B; Kurach, Ł; Michalak, A; Wronikowska, O; Zykubek, M, 2021
)
2.36
"Mephedrone is a synthetic cathinone and one of the most popular recreationally used new psychoactive substances. "( Pharmacological profile of mephedrone analogs and related new psychoactive substances.
Docci, L; Hoener, MC; Kolaczynska, KE; Krähenbühl, S; Liechti, ME; Luethi, D, 2018
)
2.22
"Mephedrone is a synthetic cathinone consumed as a recreational drug. "( Pharmacokinetics of Mephedrone and Its Metabolites in Human by LC-MS/MS.
de la Torre, R; Farré, M; Krotonoulas, A; Olesti, E; Papaseit, E; Pozo, ÓJ; Pujadas, M, 2017
)
2.22
"Mephedrone is a commonly abused constituent of "bath salts" and has many pharmacological effects in common with methamphetamine. "( Dissociation between hypothermia and neurotoxicity caused by mephedrone and methcathinone in TPH2 knockout mice.
Angoa-Perez, M; Anneken, JH; Crich, D; Kuhn, DM; Sati, GC, 2019
)
2.2
"Mephedrone is a recreationally used synthetic cathinone, relatively new abusive substances with molecular structure similar to amphetamine. "( Potential pro-oxidative effects of single dose of mephedrone in vital organs of mice.
Biała, G; Boguszewska-Czubara, A; Budzyńska, B; Jankowski, K; Tarkowski, P, 2018
)
2.18
"Mephedrone is a new psychoactive substance known to be unstable in biological matrices stored at room temperature or refrigerated. "( Stability of mephedrone and five of its phase I metabolites in human whole blood.
Abbate, V; Czerwinska, J; Dargan, PI; George, C; Kicman, AT; Parkin, MC, 2019
)
2.33
"Mephedrone is a synthetic psychostimulant derived from cathinone belonging to the family of phenylethylamines. "( [Mephedrone: a new synthetic drug].
Karila, L; Lejoyeux, M; Petit, A; Sananes, M, 2013
)
2.74
"Mephedrone (MMC) is a relatively new recreational drug that has rapidly increased in popularity in recent years. "( High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine.
Apetz, N; Bowen, MT; Callaghan, PD; Clemens, KJ; Cornish, JL; Li, KM; McGregor, IS; Motbey, CP; Ramsey, J; Winstock, AR; Wyatt, N, 2013
)
2.13
"Mephedrone is a stimulant drug of abuse with close structural and mechanistic similarities to methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA). "( Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.
Angoa-Pérez, M; Francescutti, DM; Herrera-Mundo, N; Kane, MJ; Kuhn, DM, 2014
)
2.12
"Mephedrone is a drug of abuse marketed as 'bath salts". "( Dose and time-dependent selective neurotoxicity induced by mephedrone in mice.
Abad, S; Camarasa, J; Escubedo, E; López-Arnau, R; Martínez-Clemente, J; Pubill, D, 2014
)
2.09
"Mephedrone is a new designer drug of abuse. "( Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone.
Camarasa, J; Escubedo, E; López-Arnau, R; Martínez-Clemente, J; Pubill, D; Rodrigo, T, 2015
)
2.08
"Mephedrone is a stimulant drug chemically related to amphetamine, with effects similar to those of amphetamine and cocaine. "( Deaths of individuals aged 16-24 years in the UK after using mephedrone.
Chiappini, S; Claridge, H; Corkery, JM; Gimeno Clemente, C; Goodair, C; Loi, B; Schifano, F, 2015
)
2.1
"Mephedrone is a cathinone analogue (4-methyl aromatic analogue of methcathinone) that was reported to be implicated in several fatalities in the media across Europe, but only a few have actually resulted in mephedrone cited as the cause of death."( Mephedrone related fatalities: a review.
Busardò, FP; Kyriakou, C; Marinelli, E; Napoletano, S; Zaami, S, 2015
)
2.58
"Mephedrone is a β-ketoamphetamine belonging to the family of synthetic cathinones, an emerging class of designer drugs known for their hallucinogenic and psychostimulant properties as well as for their abuse potential."( Neurotoxicity Induced by Mephedrone: An up-to-date Review.
Busardò, FP; di Luca, A; Mannocchi, G; Marinelli, E; Pacifici, R; Pantano, F; Tittarelli, R, 2017
)
2.2
"Mephedrone is a synthetic cathinone that is commonly used as a recreational drug among those who attend nightclubs. "( Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change.
Albert, S; Dargan, PI; Wood, DM, 2010
)
3.25
"Mephedrone is a synthetic derivative of cathinone which is becoming more common on the recreational drug market. "( Evidence of mephedrone chronic abuse through hair analysis using GC/MS.
Cirimele, V; Duez, M; Martin, M; Muller, JF; Turner, K, 2012
)
2.2
"Mephedrone is a designer drug recently appeared on the belgian market of the drugs of misuse. "( [Mephedrone].
Bertrand, X; Gensburger, M; Steckx, E, 2011
)
2.72
"Mephedrone is a semisynthetic derivative of cathinone used as a drug of abuse. "( [Mephedrone, the new designer drug of abuse: pharmacokinetics, pharmacodynamics and clinical and forensic issues].
Dinis-Oliveira, RJ; Magalhães, T; Ribeiro, E,
)
2.48

Effects

Mephedrone has been available in Europe since 2007. It is sold through the internet and by local shops as bath salt or plant food. It has been listed as narcotic in several European countries and more recently in France.

ExcerptReferenceRelevance
"Mephedrone has a high abuse and health risk liability, with increased tolerance, impaired control and a compulsion to use, the predominant reported dependence symptoms."( Mephedrone: use, subjective effects and health risks.
Davies, S; Marsden, J; Mitcheson, L; Puchnarewicz, M; Ramsey, J; Winstock, A, 2011
)
3.25
"Mephedrone has been recently made illegal in Europe, but little empirical evidence is available on its impact on human cognitive functions. "( Inferring about individual drug and schizotypy effects on cognitive functioning in polydrug using mephedrone users before and after clubbing.
Brooks, R; Herzig, DA; Mohr, C, 2013
)
2.05
"Mephedrone has been available in Europe since 2007, and it is sold through the internet and by local shops as bath salt or plant food."( Toxicological findings in a fatal multidrug intoxication involving mephedrone.
Bison, F; Gerace, E; Petrarulo, M; Salomone, A; Vincenti, M, 2014
)
1.36
"Mephedrone consumption has been associated with undesirable effects and fatal intoxications."( Human Pharmacology of Mephedrone in Comparison with MDMA.
de la Torre, R; Farré, M; Fonseca, F; Mateus, JA; Olesti, E; Papaseit, E; Pérez-Mañá, C; Pujadas, M; Torrens, M, 2016
)
1.47
"Mephedrone has been recently classified in both the UK and in a number of other countries as a measure to control its availability."( Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.
Albanese, A; Corazza, O; Corkery, J; Davey, Z; Deluca, P; Demetrovics, Z; Farre', M; Fergus, S; Ghodse, AH; Scherbaum, N; Schifano, F; Siemann, H; Stair, JL; Torrens, M, 2011
)
2.53
"Mephedrone has been listed as narcotic in several European countries and more recently in France."( [Mephedrone: a designer drug of recent use in France].
Boucher, A; Coquerel, A; Courné, MA; Debruyne, D; Djezzar, S; Gérardin, M; Karila, L; Le Boisselier, R; Mallaret, M,
)
1.76
"Mephedrone has been readily available for legal purchase both online and in some stores and has been promoted by aggressive Web-based marketing."( 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.
Allen, SC; Andrenyak, DM; Chu, PW; Conrad, KM; Ellis, JD; Fleckenstein, AE; German, CL; Gibb, JW; Hadlock, GC; Hanson, GR; Hoonakker, AJ; McFadden, LM; Vieira-Brock, PL; Webb, KM; Wilkins, DG, 2011
)
1.4

Actions

Mephedrone alone did not cause persistent reductions in the levels of 5HT, SERT or TPH2. Both mephedrone and MDMA enhance locomotor activity and change rectal temperature in rodents.

ExcerptReferenceRelevance
"Mephedrone alone did not cause persistent reductions in the levels of 5HT, SERT or TPH2. "( Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.
Angoa-Pérez, M; Francescutti, DM; Herrera-Mundo, N; Kane, MJ; Kuhn, DM, 2014
)
2.12
"Mephedrone does not cause toxicity to 5HT nerve endings of the hippocampus. "( Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.
Angoa-Pérez, M; Francescutti, DM; Herrera-Mundo, N; Kane, MJ; Kuhn, DM, 2014
)
2.12
"Both mephedrone and MDMA enhance locomotor activity and change rectal temperature in rodents."( The preclinical pharmacology of mephedrone; not just MDMA by another name.
Fone, KC; Green, AR; King, MV; Shortall, SE, 2014
)
1.14
"Mephedrone and MDPV produce opposite electrophysiological signatures through hDAT expressed in oocytes. "( Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
Cameron, K; De Felice, L; Glennon, RA; Kolanos, R; Vekariya, R; Verkariya, R, 2013
)
3.28

Treatment

ExcerptReferenceRelevance
"For mephedrone, chronic treatment produced partial tolerance to ICSS depression and enhanced expression of ICSS facilitation."( Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats.
Banks, ML; Negus, SS; Suyama, JA, 2019
)
1.25

Toxicity

Study shows strong cytotoxic potential for the NPS 5F-PB-22 and MDAI. Moderate effects for MDMA, MDPV, methylone, cathinone, 4-MEC, and mephedrone. No toxic effects for methamphetamine.

ExcerptReferenceRelevance
" Sympathomimetic adverse effects are common and severe effects are also reported."( Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service.
Adams, RD; Cooper, G; James, D; Lupton, DJ; Spears, R; Thomas, SH; Thompson, JP, 2011
)
0.66
"To review and improve the evidence base regarding the toxic effects of Mephedrone, a cathinone derivative which was first believed to have been synthesised and propagated in 2007."( Mephedrone toxicity in a Scottish emergency department.
Macdonald, C; Mitchelson, M; Regan, L, 2011
)
2.05
" None of the respondents reported that the once-legal status of mephedrone implied that it was safe to use."( Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply.
McElrath, K; O'Neill, C, 2011
)
0.95
"Reported ingestion of benzofuran compounds is associated with similar toxic effects to those of amphetamines and cathinones."( Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the 'benzofuran' compounds. A report from the United Kingdom National Poisons Information Service.
Cooper, G; Eddleston, M; Hill, SL; James, D; Kamour, A; Lupton, DJ; Thanacoody, R; Thomas, SH; Thompson, JP; Vale, A, 2014
)
0.4
" In conclusion, the study suggests a potentially dangerous effect of concomitant caffeine and mephedrone, and highlights the importance of taking polydrug use into consideration when investigating the acute adverse effect profile of popular recreational drugs."( Caffeine alters the behavioural and body temperature responses to mephedrone without causing long-term neurotoxicity in rats.
Fone, KC; Green, AR; King, MV; Shortall, SE, 2016
)
0.89
" The present study showed strong cytotoxic potential for the NPS 5F-PB-22 and MDAI, moderate effects for MDMA, MDPV, methylone, cathinone, 4-MEC, and mephedrone, and no toxic effects for methamphetamine."( Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay.
Beck, A; Flockerzi, V; Maurer, HH; Meyer, MR; Richter, LHJ, 2019
)
0.71

Pharmacokinetics

Dihydro-mephedrone represented 10% of the amount of mephedrone in plasma. N-succinyl-nor-mepingrone was the metabolite eliminated with the longer half-life of 8. Compared to other psychostimulants, mephedon showed rapid absorption.

ExcerptReferenceRelevance
" A pharmacokinetic curve for the incurred phentermine was successfully produced using the described validated method."( Hematocrit-Independent Quantitation of Stimulants in Dried Blood Spots: Pipet versus Microfluidic-Based Volumetric Sampling Coupled with Automated Flow-Through Desorption and Online Solid Phase Extraction-LC-MS/MS Bioanalysis.
Henion, J; Verplaetse, R, 2016
)
0.43
" Several methods able to detect mephedrone have been reported, although to date, none have been applied to human pharmacokinetic studies in a controlled setting."( GC-MS Quantification Method for Mephedrone in Plasma and Urine: Application to Human Pharmacokinetics.
de la Torre, R; Farré, M; Olesti, E; Papaseit, E; Pérez-Mañá, C; Pozo, ÓJ; Pujadas, M, 2017
)
1.02
" As such, the purpose of this study was to examine the pharmacokinetic profile of the 'bath salts' in a pregnancy model."( The pharmacokinetic profile of synthetic cathinones in a pregnancy model.
Brown, SD; Keasling, R; Kochelek, K; Pond, BB; Strange, LG, 2017
)
0.46
" The pharmacokinetic profiles of the synthetic cathinones vary based on the substitutions to the core scaffold."( A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics.
Calinski, DM; Kisor, DF; Sprague, JE, 2019
)
0.51
"To provide a summary of the literature regarding the pharmacokinetic characteristics of the synthetic cathinones, with a focus on the impact of the structural modifications to the pharmacokinetics."( A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics.
Calinski, DM; Kisor, DF; Sprague, JE, 2019
)
0.51
"In many, but not all, instances the pharmacokinetic characteristics of the synthetic cathinones can be reasonably predicted based on the substitutions to the core scaffold."( A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics.
Calinski, DM; Kisor, DF; Sprague, JE, 2019
)
0.51
"Continued research will lead to a better understanding of the pharmacokinetic changes associated with structural modifications to the cathinone scaffold, and potentially in the long range, enhanced overdose and addiction therapy."( A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics.
Calinski, DM; Kisor, DF; Sprague, JE, 2019
)
0.51
" Compared to other psychostimulants, mephedrone showed rapid absorption (mean Tmax of 52."( Pharmacokinetics of Mephedrone and Its Metabolites in Whole Blood and Plasma after Controlled Intranasal Administration to Healthy Human Volunteers.
Abbate, V; Czerwinska, J; Dargan, PI; George, C; Kicman, AT; Parkin, MC, 2021
)
1.22
" In this study, we examine the pharmacokinetic interactions of the drug combination."( Pharmacokinetics of Synthetic Cathinones Found in Bath Salts in Mouse Brain and Plasma Using High-Pressure Liquid Chromatography-Tandem Mass Spectrometry.
Bouldin, JB; Brown, SD; Gearlds, C; McKinney, M; Pond, BB; Schreiner, S, 2021
)
0.62

Compound-Compound Interactions

ExcerptReferenceRelevance
" Synthetic cathinones are frequently consumed in combination with other drugs of abuse."( Bath salts and polyconsumption: in search of drug-drug interactions.
Lopez-Rodriguez, AB; Viveros, MP, 2019
)
0.51

Bioavailability

The method has been successfully applied to biological samples obtained from a pilot clinical trial. The absolute bioavailability of mephedrone was about 10% and the percentage of me phedrone protein binding was 21.

ExcerptReferenceRelevance
" The absolute bioavailability of mephedrone was about 10% and the percentage of mephedrone protein binding was 21."( Mephedrone pharmacokinetics after intravenous and oral administration in rats: relation to pharmacodynamics.
Camarasa, J; Carbó, M; Escubedo, E; López-Arnau, R; Martínez-Clemente, J; Pubill, D, 2013
)
2.11
" The method has been successfully applied to biological samples obtained from a pilot clinical trial intended to evaluate the human pharmacology of mephedrone and its relative bioavailability and pharmacokinetics."( GC-MS Quantification Method for Mephedrone in Plasma and Urine: Application to Human Pharmacokinetics.
de la Torre, R; Farré, M; Olesti, E; Papaseit, E; Pérez-Mañá, C; Pozo, ÓJ; Pujadas, M, 2017
)
0.94

Dosage Studied

ExcerptRelevanceReference
" Dopamine, 5-hydroxytryptamine (5-HT) and their major metabolites were measured in striatum, frontal cortex and hippocampus by high performance liquid chromatography 7 days after intermittent dosing and 2h after acute injection."( Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat.
Ebling, FJ; Fone, KC; Jayson, R; King, MV; Korsah, C; Macerola, AE; Pillidge, KE; Richard Green, A; Shortall, SE; Swaby, RT; Wigmore, PM, 2013
)
0.62
" Dose-response functions were then established under fixed- and progressive-ratio (FR and PR) schedules over three subsequent weeks of testing."( High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine.
Apetz, N; Bowen, MT; Callaghan, PD; Clemens, KJ; Cornish, JL; Li, KM; McGregor, IS; Motbey, CP; Ramsey, J; Winstock, AR; Wyatt, N, 2013
)
0.69
", following repeated daily exposure), and across context-independent and -dependent dosing schedules."( Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats.
Gregg, RA; McCurdy, C; Rawls, SM; Reitz, A; Tallarida, CS, 2013
)
1.83
" Four 25 mg/kg injections of mephedrone increased NT content in basal ganglia (striatum, substantia nigra and globus pallidus) and the limbic regions (nucleus accumbens core), while a lower dosage (5 mg/kg/injection) only increased striatal NT content."( Mephedrone alters basal ganglia and limbic neurotensin systems.
Fleckenstein, AE; German, CL; Hanson, GR; Hoonakker, AH, 2014
)
2.14
" The secondary aims were to investigate a possible dose-response CPP and whether the synthetic cathinones induce higher CPP than amphetamine at equal dose."( Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice.
Andersson, M; Karlsson, L; Kronstrand, R; Kugelberg, FC, 2014
)
1.85
" Testing for purity, "allergy testing," and gauging of dosage were common."( An Internet Study of User's Experiences of the Synthetic Cathinone 4-Methylethcathinone (4-MEC).
Van Hout, MC,
)
0.13
" As relatively new drugs on the gay scene, understanding of appropriate dosing was lacking and a majority described overdoses, particularly in relation to GHB/GBL."( "Chemsex" and harm reduction need among gay men in South London.
Bourne, A; Hickson, F; Reid, D; Steinberg, P; Torres-Rueda, S; Weatherburn, P, 2015
)
0.42
" The urine of rats dosed with a subcutaneous bolus dose of 20mg 4-MMC/kg was analysed by LC/MS."( Metabolic profile of mephedrone: Identification of nor-mephedrone conjugates with dicarboxylic acids as a new type of xenobiotic phase II metabolites.
Balíková, M; Himl, M; Lhotková, E; Linhart, I; Páleníček, T; Židková, M, 2016
)
0.75
" Dose-response curves were then generated with AMPH (0."( Effects of D1 and D2 receptor antagonists on the discriminative stimulus effects of methylendioxypyrovalerone and mephedrone in male Sprague-Dawley rats trained to discriminate D-amphetamine.
Baker, LE; Burroughs, RL; Harvey, EL, 2017
)
0.67
"32 mg/kg/inf) under a fixed ratio (FR) 1 schedule of reinforcement; and (2) full dose-response curves for each drug to maintain responding under an FR5 schedule of reinforcement."( Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.
Collins, GT; Galindo, KI; Gannon, BM; Mesmin, MP; Rice, KC; Sulima, A, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
amphetaminesAmines that constitute a class of central nervous system stimulants based on the structure of the parent amphetamine 1-phenylpropan-2-amine.
aromatic ketoneA ketone in which the carbonyl group is attached to an aromatic ring.
secondary amino compoundA compound formally derived from ammonia by replacing two hydrogen atoms by organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sodium-dependent serotonin transporterHomo sapiens (human)EC50 (µMol)0.11800.00112.38838.7000AID1442376
Sodium-dependent dopamine transporter Homo sapiens (human)EC50 (µMol)0.04910.01250.76681.7000AID1442377
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (52)

Processvia Protein(s)Taxonomy
monoamine transportSodium-dependent serotonin transporterHomo sapiens (human)
response to hypoxiaSodium-dependent serotonin transporterHomo sapiens (human)
neurotransmitter transportSodium-dependent serotonin transporterHomo sapiens (human)
response to nutrientSodium-dependent serotonin transporterHomo sapiens (human)
memorySodium-dependent serotonin transporterHomo sapiens (human)
circadian rhythmSodium-dependent serotonin transporterHomo sapiens (human)
response to xenobiotic stimulusSodium-dependent serotonin transporterHomo sapiens (human)
response to toxic substanceSodium-dependent serotonin transporterHomo sapiens (human)
positive regulation of gene expressionSodium-dependent serotonin transporterHomo sapiens (human)
positive regulation of serotonin secretionSodium-dependent serotonin transporterHomo sapiens (human)
negative regulation of cerebellar granule cell precursor proliferationSodium-dependent serotonin transporterHomo sapiens (human)
negative regulation of synaptic transmission, dopaminergicSodium-dependent serotonin transporterHomo sapiens (human)
response to estradiolSodium-dependent serotonin transporterHomo sapiens (human)
social behaviorSodium-dependent serotonin transporterHomo sapiens (human)
vasoconstrictionSodium-dependent serotonin transporterHomo sapiens (human)
sperm ejaculationSodium-dependent serotonin transporterHomo sapiens (human)
negative regulation of neuron differentiationSodium-dependent serotonin transporterHomo sapiens (human)
positive regulation of cell cycleSodium-dependent serotonin transporterHomo sapiens (human)
negative regulation of organ growthSodium-dependent serotonin transporterHomo sapiens (human)
behavioral response to cocaineSodium-dependent serotonin transporterHomo sapiens (human)
enteric nervous system developmentSodium-dependent serotonin transporterHomo sapiens (human)
brain morphogenesisSodium-dependent serotonin transporterHomo sapiens (human)
serotonin uptakeSodium-dependent serotonin transporterHomo sapiens (human)
membrane depolarizationSodium-dependent serotonin transporterHomo sapiens (human)
platelet aggregationSodium-dependent serotonin transporterHomo sapiens (human)
cellular response to retinoic acidSodium-dependent serotonin transporterHomo sapiens (human)
cellular response to cGMPSodium-dependent serotonin transporterHomo sapiens (human)
regulation of thalamus sizeSodium-dependent serotonin transporterHomo sapiens (human)
conditioned place preferenceSodium-dependent serotonin transporterHomo sapiens (human)
sodium ion transmembrane transportSodium-dependent serotonin transporterHomo sapiens (human)
amino acid transportSodium-dependent serotonin transporterHomo sapiens (human)
monoamine transportSodium-dependent dopamine transporter Homo sapiens (human)
neurotransmitter transportSodium-dependent dopamine transporter Homo sapiens (human)
lactationSodium-dependent dopamine transporter Homo sapiens (human)
sensory perception of smellSodium-dependent dopamine transporter Homo sapiens (human)
locomotory behaviorSodium-dependent dopamine transporter Homo sapiens (human)
response to xenobiotic stimulusSodium-dependent dopamine transporter Homo sapiens (human)
response to iron ionSodium-dependent dopamine transporter Homo sapiens (human)
dopamine transportSodium-dependent dopamine transporter Homo sapiens (human)
adenohypophysis developmentSodium-dependent dopamine transporter Homo sapiens (human)
response to nicotineSodium-dependent dopamine transporter Homo sapiens (human)
positive regulation of multicellular organism growthSodium-dependent dopamine transporter Homo sapiens (human)
regulation of dopamine metabolic processSodium-dependent dopamine transporter Homo sapiens (human)
response to cocaineSodium-dependent dopamine transporter Homo sapiens (human)
dopamine biosynthetic processSodium-dependent dopamine transporter Homo sapiens (human)
dopamine catabolic processSodium-dependent dopamine transporter Homo sapiens (human)
response to ethanolSodium-dependent dopamine transporter Homo sapiens (human)
cognitionSodium-dependent dopamine transporter Homo sapiens (human)
dopamine uptake involved in synaptic transmissionSodium-dependent dopamine transporter Homo sapiens (human)
response to cAMPSodium-dependent dopamine transporter Homo sapiens (human)
norepinephrine uptakeSodium-dependent dopamine transporter Homo sapiens (human)
prepulse inhibitionSodium-dependent dopamine transporter Homo sapiens (human)
dopamine uptakeSodium-dependent dopamine transporter Homo sapiens (human)
hyaloid vascular plexus regressionSodium-dependent dopamine transporter Homo sapiens (human)
amino acid transportSodium-dependent dopamine transporter Homo sapiens (human)
norepinephrine transportSodium-dependent dopamine transporter Homo sapiens (human)
sodium ion transmembrane transportSodium-dependent dopamine transporter Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (24)

Processvia Protein(s)Taxonomy
integrin bindingSodium-dependent serotonin transporterHomo sapiens (human)
monoatomic cation channel activitySodium-dependent serotonin transporterHomo sapiens (human)
neurotransmitter transmembrane transporter activitySodium-dependent serotonin transporterHomo sapiens (human)
serotonin:sodium:chloride symporter activitySodium-dependent serotonin transporterHomo sapiens (human)
protein bindingSodium-dependent serotonin transporterHomo sapiens (human)
monoamine transmembrane transporter activitySodium-dependent serotonin transporterHomo sapiens (human)
antiporter activitySodium-dependent serotonin transporterHomo sapiens (human)
syntaxin-1 bindingSodium-dependent serotonin transporterHomo sapiens (human)
cocaine bindingSodium-dependent serotonin transporterHomo sapiens (human)
sodium ion bindingSodium-dependent serotonin transporterHomo sapiens (human)
identical protein bindingSodium-dependent serotonin transporterHomo sapiens (human)
nitric-oxide synthase bindingSodium-dependent serotonin transporterHomo sapiens (human)
actin filament bindingSodium-dependent serotonin transporterHomo sapiens (human)
serotonin bindingSodium-dependent serotonin transporterHomo sapiens (human)
protease bindingSodium-dependent dopamine transporter Homo sapiens (human)
signaling receptor bindingSodium-dependent dopamine transporter Homo sapiens (human)
neurotransmitter transmembrane transporter activitySodium-dependent dopamine transporter Homo sapiens (human)
dopamine:sodium symporter activitySodium-dependent dopamine transporter Homo sapiens (human)
protein bindingSodium-dependent dopamine transporter Homo sapiens (human)
monoamine transmembrane transporter activitySodium-dependent dopamine transporter Homo sapiens (human)
dopamine bindingSodium-dependent dopamine transporter Homo sapiens (human)
amine bindingSodium-dependent dopamine transporter Homo sapiens (human)
protein-containing complex bindingSodium-dependent dopamine transporter Homo sapiens (human)
metal ion bindingSodium-dependent dopamine transporter Homo sapiens (human)
protein phosphatase 2A bindingSodium-dependent dopamine transporter Homo sapiens (human)
heterocyclic compound bindingSodium-dependent dopamine transporter Homo sapiens (human)
norepinephrine:sodium symporter activitySodium-dependent dopamine transporter Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
plasma membraneSodium-dependent serotonin transporterHomo sapiens (human)
focal adhesionSodium-dependent serotonin transporterHomo sapiens (human)
endosome membraneSodium-dependent serotonin transporterHomo sapiens (human)
endomembrane systemSodium-dependent serotonin transporterHomo sapiens (human)
presynaptic membraneSodium-dependent serotonin transporterHomo sapiens (human)
membrane raftSodium-dependent serotonin transporterHomo sapiens (human)
synapseSodium-dependent serotonin transporterHomo sapiens (human)
postsynaptic membraneSodium-dependent serotonin transporterHomo sapiens (human)
serotonergic synapseSodium-dependent serotonin transporterHomo sapiens (human)
synapseSodium-dependent serotonin transporterHomo sapiens (human)
plasma membraneSodium-dependent serotonin transporterHomo sapiens (human)
neuron projectionSodium-dependent serotonin transporterHomo sapiens (human)
cytoplasmSodium-dependent dopamine transporter Homo sapiens (human)
plasma membraneSodium-dependent dopamine transporter Homo sapiens (human)
cell surfaceSodium-dependent dopamine transporter Homo sapiens (human)
membraneSodium-dependent dopamine transporter Homo sapiens (human)
axonSodium-dependent dopamine transporter Homo sapiens (human)
neuron projectionSodium-dependent dopamine transporter Homo sapiens (human)
neuronal cell bodySodium-dependent dopamine transporter Homo sapiens (human)
axon terminusSodium-dependent dopamine transporter Homo sapiens (human)
membrane raftSodium-dependent dopamine transporter Homo sapiens (human)
postsynaptic membraneSodium-dependent dopamine transporter Homo sapiens (human)
dopaminergic synapseSodium-dependent dopamine transporter Homo sapiens (human)
flotillin complexSodium-dependent dopamine transporter Homo sapiens (human)
axonSodium-dependent dopamine transporter Homo sapiens (human)
presynaptic membraneSodium-dependent dopamine transporter Homo sapiens (human)
plasma membraneSodium-dependent dopamine transporter Homo sapiens (human)
neuronal cell body membraneSodium-dependent dopamine transporter Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1442377Activity at DAT (unknown origin) assessed as release of [3H]DA2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
AID1442378Selectivity ratio of EC50 for SERT (unknown origin) assessed as release of [3H]HT to EC50 for DAT (unknown origin) by [3H]DA release assay2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
AID1442376Activity at SERT (unknown origin) assessed as release of [3H]HT2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (347)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's303 (87.32)24.3611
2020's44 (12.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (0.82%)5.53%
Reviews43 (11.68%)6.00%
Case Studies42 (11.41%)4.05%
Observational2 (0.54%)0.25%
Other278 (75.54%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]